Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

The drug was approved to treat cerebral folate deficiency, a rare genetic condition.

After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust.

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA ...

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

The U.S. Food and Drug Administration on Tuesday approved leucovorin, a synthetic form of vitamin B9, as a treatment for a rare genetic condition that causes folate deficiencies in the brain. The ...

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...

By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a ...

The Trump administration appears to be walking back its statements from last year that the prescription drug leucovorin can be used to treat certain patients with autism. The Food and Drug ...